Postdoctoral Training Program in Pulmonary and Critical Care Translational Research

肺部和重症监护转化研究博士后培训项目

基本信息

  • 批准号:
    10198029
  • 负责人:
  • 金额:
    $ 34.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-07-01 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract We enthusiastically submit this revised application for our T32 training program here at the University of Illinois at Chicago (UIC) entitled Postdoctoral Training Program in Pulmonary and Critical Care Translational Research. The primary goal of our program is the career development of the next generation of scientific leaders in the fields of pulmonary and critical care medicine along three integrated thematic pathways that provide comprehensive training in 1) Lung Injury and Inflammation, 2) Precision Medicine and Computational Approaches, and 3) Comparative Effectiveness and Health Inequality. This innovative new program builds upon our experience and success achieved over a recent 10 year period with a prior postdoctoral T32 based here in our Division of Pulmonary, Critical Care, Sleep, and Allergy. This prior program had an outstanding trajectory of success, with our recent T32 trainees earning 3 new K08s, 1 K23, and 1 R01 in the past two years alone. Moreover, 13 out of the last 18 T32 fellows in our prior program continue to pursue scientifically-oriented careers. With this new program, we build upon this impressive history of success and have substantially advanced and expanded our training environment through the recruitment of multiple new faculty. The addition of their various areas of scientific expertise brings new state-of-the-art dimensions to our training environment. Our underlying premise and unifying hypothesis is that an integrated program focused on cutting-edge research approaches will inspire a new generation of successful scientific leaders in lung diseases. With frequent input and feedback from faculty, trainees, and internal and external advisors, we continually enhance and improve our training program to optimize the career development and scientific success of our trainees. Major programmatic enhancements in this new program include the following:  Faculty expansion and development have added training opportunities in multiple new fields—lung microbiome, sarcoidosis, lung cancer, precision medicine, computational modeling, healthcare design, population health science  Transition to a multi-PI leadership structure to optimize program oversight and growth  Detailed description of current training timeline and trainee milestones  Formation of a Minority Advisory Committee  Incorporation of former T32 trainees and junior faculty into the program as “near peer” advisors  Required training in scientific rigor and reproducibility for T32 trainees  Expanded annual training in mentorship that is required for faculty  Incorporation of a PhD Training Committee to enhance recruitment and training of PhD candidates  “360 degree evaluation” with emphasis on current and former trainee program reviews at annual retreat Candidates will be accepted for 2-3 years of research training based on exceptional personal qualifications.
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STEVEN M DUDEK其他文献

STEVEN M DUDEK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STEVEN M DUDEK', 18)}}的其他基金

Pathobiology of MRSA-induced Endothelial Permeability and Acute Lung Injury
MRSA 诱导的内皮通透性和急性肺损伤的病理学
  • 批准号:
    10608606
  • 财政年份:
    2022
  • 资助金额:
    $ 34.19万
  • 项目类别:
Patient Sampling and Genomics Core
患者采样和基因组学核心
  • 批准号:
    10701927
  • 财政年份:
    2021
  • 资助金额:
    $ 34.19万
  • 项目类别:
Patient Sampling and Genomics Core
患者采样和基因组学核心
  • 批准号:
    10491060
  • 财政年份:
    2021
  • 资助金额:
    $ 34.19万
  • 项目类别:
Fostering Academic Physician-Investigators Treating High Risk Populations
培养治疗高危人群的学术医师研究人员
  • 批准号:
    10647841
  • 财政年份:
    2021
  • 资助金额:
    $ 34.19万
  • 项目类别:
Fostering Academic Physician-Investigators Treating High Risk Populations
培养治疗高危人群的学术医师研究人员
  • 批准号:
    10459247
  • 财政年份:
    2021
  • 资助金额:
    $ 34.19万
  • 项目类别:
Patient Sampling and Genomics Core
患者采样和基因组学核心
  • 批准号:
    10170862
  • 财政年份:
    2021
  • 资助金额:
    $ 34.19万
  • 项目类别:
Postdoctoral Training Program in Pulmonary and Critical Care Translational Research
肺部和重症监护转化研究博士后培训项目
  • 批准号:
    10472480
  • 财政年份:
    2019
  • 资助金额:
    $ 34.19万
  • 项目类别:
Postdoctoral Training Program in Pulmonary and Critical Care Translational Research
肺部和重症监护转化研究博士后培训项目
  • 批准号:
    10700843
  • 财政年份:
    2019
  • 资助金额:
    $ 34.19万
  • 项目类别:
Postdoctoral Training Program in Pulmonary and Critical Care Translational Research
肺部和重症监护转化研究博士后培训项目
  • 批准号:
    9791769
  • 财政年份:
    2019
  • 资助金额:
    $ 34.19万
  • 项目类别:
Crosstalk between S1P Receptor 1/S1P1 and P-Selectin/Selp in Regulation of Inflammatory Vascular Permeability
S1P 受体 1/S1P1 和 P-选择素/Selp 之间的串扰调节炎症血管通透性
  • 批准号:
    10871784
  • 财政年份:
    2016
  • 资助金额:
    $ 34.19万
  • 项目类别:

相似国自然基金

胚胎脑发育的分子机理:lgl2(late gestation lung 2)蛋白质的生物学功能的研究
  • 批准号:
    30470854
  • 批准年份:
    2004
  • 资助金额:
    18.0 万元
  • 项目类别:
    面上项目

相似海外基金

Interplay of the extracellular matrix and immune cells in lung pathology: key role for chitinase-like proteins
肺病理学中细胞外基质和免疫细胞的相互作用:几丁质酶样蛋白的关键作用
  • 批准号:
    MR/Y003683/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.19万
  • 项目类别:
    Research Grant
Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tazemetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer
EZH2 抑制剂、他泽美司他和 PD-1 阻断治疗晚期非小细胞肺癌的安全性和有效性的 Ib/II 期研究
  • 批准号:
    10481965
  • 财政年份:
    2024
  • 资助金额:
    $ 34.19万
  • 项目类别:
Uncovering the epigenetic face of lung fibrosis for discovery of novel biomarkers and treatments.
揭示肺纤维化的表观遗传面,以发现新的生物标志物和治疗方法。
  • 批准号:
    MR/X032914/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.19万
  • 项目类别:
    Fellowship
Persistent micro- and nanoplastics as triggers for interstitial lung disease
持久性微塑料和纳米塑料是间质性肺病的诱因
  • 批准号:
    MR/Y012682/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.19万
  • 项目类别:
    Research Grant
気道上皮バリアに着目した肺NTM症Lung-on-a-chipモデルの構築と応用
关注气道上皮屏障的肺NTM疾病芯片肺模型的构建与应用
  • 批准号:
    24K19096
  • 财政年份:
    2024
  • 资助金额:
    $ 34.19万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 34.19万
  • 项目类别:
Interaction between immunity and airway remodelling in lung disease.
肺部疾病中免疫与气道重塑之间的相互作用。
  • 批准号:
    502582
  • 财政年份:
    2024
  • 资助金额:
    $ 34.19万
  • 项目类别:
Bioactive fragments of the extracellular matrix orchestrate lung epithelial cell repair.
细胞外基质的生物活性片段协调肺上皮细胞修复。
  • 批准号:
    BB/Y004183/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.19万
  • 项目类别:
    Research Grant
Tractable human distal lung organoid model as a new efficient tool to study mesenchymal-epithelial interactions in COPD
易处理的人远端肺类器官模型作为研究慢性阻塞性肺病间充质-上皮相互作用的新有效工具
  • 批准号:
    NC/Y500641/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.19万
  • 项目类别:
    Training Grant
Cellular dynamics in chronic lung disease: the neglected B cell axis
慢性肺病的细胞动力学:被忽视的 B 细胞轴
  • 批准号:
    MR/X03383X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.19万
  • 项目类别:
    Fellowship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了